The expansion of our Centre of Excellence for softgels manufacturing in Miami, USA, with the addition of a 6th manufacturing line, further enhances the site’s production capacity and operational flexibility. This investment enables greater parallel processing, improved scheduling agility, and strengthens redundancy across lines to support improved run time and continuity of supply.

For our customers, the 6th line reinforces reliability and responsiveness, supports scalable growth, and maintains consistent quality while meeting evolving customer needs.

Learn more about our softgel capabilities here: Vertically integrated CDMO softgels